Entering text into the input field will update the search result below

PTC Therapeutics, Inc. (PTCT) CEO Stuart Peltz on Q1 2022 Results - Earnings Call Transcript

May 04, 2022 12:23 AM ETPTC Therapeutics, Inc. (PTCT)
SA Transcripts profile picture
SA Transcripts

Start Time: 16:30 January 1, 0000 5:36 PM ET

PTC Therapeutics, Inc. (NASDAQ:PTCT)

Q1 2022 Earnings Conference Call

May 03, 2022, 16:30 PM ET

Company Participants

Stuart Peltz - Founder and CEO

Matthew Klein - COO

Eric Pauwels - Chief Business Officer

Emily Hill - CFO

Kylie O’Keefe - SVP, Global Commercial and Corporate Strategy

Conference Call Participants

Eric Joseph - JPMorgan

Rick Krause - Cantor Fitzgerald

Brian Abrahams - RBC Capital Markets

Joseph Thome - Cowen and Company

Gena Wang - Barclays

Robyn Karnauskas - Truist Securities

Alex Sklar - Raymond James

Colin Bristow - UBS


Ladies and gentlemen, thank you for standing by. Welcome to the PTC First Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions].

I would now like to turn the call over to your host, Kyle O’Keefe. You may begin.

Kylie O’Keefe

Good afternoon and thank you for joining us today to discuss the PTC Therapeutics first 2022 corporate update and financial results. I am joined today by our Chief Executive Officer, Stuart Peltz; our Chief Operating Officer, Matthew Klein; our Chief Business Officer, Eric Pauwels; and our Chief Financial Officer, Emily Hill.

Today's call will include forward-looking statements based on current expectations. Please take a moment to review the slide posted on our Investor Relations Web site in conjunction with the call, which contains our forward-looking statements. Our actual results could materially differ from these forward-looking statements as such statements are subject to risks that can materially and adversely affect our business and results of operations.

For a detailed description of applicable risks and uncertainties, we encourage you to review the company's most recent annual report on Form 10-K and quarterly report on Form

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About PTCT

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on PTCT

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.